$10.61
-1.36-11.36%
In chiusura: -
$10.56
-0.05-0.47%
After hour: 5:06 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Enanta Pharmaceuticals Inc (NASDAQ:ENTA) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 2.83M a 2.85M. Questo rappresenta il 14.16% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Enanta Pharma Corp (XNAS:ENTA) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 206.73K azioni scambiate al giorno, ci vorrebbero 13.78 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
2.85M
Vendite allo scoperto %
14.2%
Giorni di copertura
13.78
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ENTA | Enanta Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 14.16% | 20,124,121 | 2,848,661 | 206,730 | 13.78 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 14.08% | 20,124,121 | 2,833,975 | 143,358 | 19.77 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 14.34% | 20,124,121 | 2,884,903 | 144,673 | 19.94 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 13.57% | 20,122,779 | 2,731,581 | 196,572 | 13.9 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 12.24% | 20,122,779 | 2,463,124 | 157,567 | 15.63 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 12.05% | 20,122,779 | 2,423,818 | 138,920 | 17.45 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 12.42% | 20,122,779 | 2,498,915 | 237,356 | 10.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 13.53% | 20,122,779 | 2,721,617 | 105,008 | 25.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 14.19% | 20,122,779 | 2,854,687 | 134,930 | 21.16 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 14.73% | 20,078,742 | 2,957,157 | 181,451 | 16.3 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 13.96% | 20,078,742 | 2,803,726 | 315,454 | 8.89 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 13.28% | 20,078,742 | 2,667,145 | 201,024 | 13.27 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 13.11% | 20,078,742 | 2,632,482 | 262,336 | 10.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 12.94% | 20,078,742 | 2,598,257 | 523,491 | 4.96 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 17.79% | 20,078,742 | 3,572,627 | 603,837 | 5.92 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 16.76% | 20,078,742 | 3,364,560 | 366,653 | 9.18 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 16.22% | 19,933,548 | 3,232,743 | 741,016 | 4.36 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 16.79% | 19,933,548 | 3,347,388 | 717,663 | 4.66 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 16.91% | 19,933,548 | 3,371,327 | 575,287 | 5.86 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 16.21% | 19,933,548 | 3,231,310 | 311,534 | 10.37 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 16.95% | 19,927,793 | 3,378,684 | 100,767 | 33.53 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 17.26% | 19,927,793 | 3,440,099 | 122,820 | 28.01 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 17.20% | 19,927,793 | 3,427,004 | 184,142 | 18.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 14.98% | 19,927,793 | 2,985,735 | 212,865 | 14.03 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 14.64% | 19,927,793 | 2,917,239 | 124,692 | 23.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 14.61% | 19,927,793 | 2,910,550 | 126,851 | 22.94 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 14.84% | 19,927,793 | 2,957,765 | 190,993 | 15.49 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 14.05% | 19,927,793 | 2,800,039 | 129,943 | 21.55 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 14.61% | 19,918,622 | 2,910,636 | 224,224 | 12.98 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 15.12% | 19,918,622 | 3,012,010 | 224,860 | 13.4 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 13.84% | 19,918,622 | 2,755,876 | 225,212 | 12.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 13.85% | 19,918,622 | 2,759,266 | 128,111 | 21.54 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 14.06% | 19,918,622 | 2,800,265 | 138,343 | 20.24 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 13.96% | 19,918,622 | 2,781,478 | 134,485 | 20.68 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 13.80% | 19,895,205 | 2,744,555 | 205,130 | 13.38 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 13.79% | 19,895,205 | 2,742,991 | 301,497 | 9.1 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 12.11% | 19,895,205 | 2,409,754 | 207,613 | 11.61 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 10.48% | 19,895,205 | 2,085,486 | 209,676 | 9.95 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 11.11% | 19,895,205 | 2,209,504 | 298,823 | 7.39 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 9.25% | 19,895,205 | 1,840,415 | 243,174 | 7.57 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 9.76% | 16,329,123 | 1,593,413 | 396,445 | 4.02 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 9.50% | 16,329,123 | 1,550,818 | 156,440 | 9.91 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 11.01% | 16,329,123 | 1,798,411 | 232,512 | 7.73 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 9.00% | 16,329,123 | 1,469,536 | 345,771 | 4.25 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 9.22% | 16,329,123 | 1,505,578 | 319,851 | 4.71 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 8.18% | 16,325,590 | 1,336,144 | 273,459 | 4.89 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 10/13/2023 | 10/24/2023 | 7.88% | 16,325,590 | 1,286,868 | 304,397 | 4.23 | |
ENTA | Enanta Pharmaceuticals, Inc. C | 09/29/2023 | 10/10/2023 | 7.29% | 16,325,590 | 1,190,921 | 437,654 | 2.72 |
In cerca di azioni più vendute allo scoperto?